Code of Publishing Ethics
International Pharmacy Acta upholds rigorous standards of integrity across all stages of scientific evaluation and dissemination. The journal adheres to the Core Practices of the Committee on Publication Ethics and the Recommendations of the International Committee of Medical Journal Editors. This code defines the responsibilities required of authors, reviewers, the editorial board, and the publisher.
Duties of Authors
Reporting Standards and Originality
Authors of original pharmaceutical and biomedical research must present an accurate account of the work performed, followed by an objective discussion of its significance. Underlying data must be represented accurately in the manuscript. Submissions must contain sufficient detail and empirical references to permit others to replicate the experiments. The presentation of fraudulent or knowingly inaccurate statements constitutes unethical behavior and is unacceptable.
Authors must ensure that they have written entirely original works. When authors use the work, ideas, or words of others, these must be cited appropriately. Submitting the same manuscript to more than one journal concurrently is prohibited. Plagiarism in any form, including verbatim copying of text, uncredited paraphrasing, and appropriation of research materials, constitutes serious academic misconduct.
Data Access and Retention
Authors may be asked to provide the raw research data supporting their paper for editorial review. Authors should be prepared to retain such data for a reasonable time following publication and provide public access if practicable, provided that the confidentiality of participants and proprietary rights are protected.
Authorship and Contributorship
Authorship must be limited strictly to those who meet all four ICMJE criteria:
Substantial contributions to the conception or design of the work, or the acquisition, analysis, or interpretation of data.Drafting the work or revising it critically for important intellectual content.Final approval of the version to be published.Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part are appropriately investigated and resolved.All individuals who made substantial contributions to the work reported in the manuscript but who do not meet the criteria for authorship must be named in the Acknowledgments section, alongside written permission to be named. The corresponding author ensures that all co-authors have approved the final manuscript and agreed to its submission.
Changes in Authorship
Any addition, deletion, or rearrangement of author names in the authorship list requires formal written justification from the corresponding author, along with signed agreement from all listed authors, including those being added or removed. In compliance with COPE standards, changes to authorship after manuscript acceptance are permitted only under exceptional circumstances with the direct approval of the Editor-in-Chief.
Disclosure of Conflicts of Interest and Funding
All authors must disclose any financial or personal relationships that could inappropriately influence their work. Potential conflicts include employment, consultancies, stock ownership, honoraria, patent applications, or grant funding. All sources of financial support for the conduct of the research must be disclosed in the manuscript.
Ethical Approval, Consent, and Confidentiality
Research involving human subjects must conform to the Declaration of Helsinki and must receive prior approval from an institutional review board or an accredited ethics committee, including the National Committee for Ethics in Biomedical Research for studies conducted in Iran. The official approval code must be stated in the text. Informed written consent must be obtained from human subjects for participation and for the publication of identifiable data. Animal experimentation must comply with institutional and national welfare guidelines, including the ARRIVE parameter
s, with institutional ethics committee approval explicitly stated. Clinical interventional trials must be prospectively registered in a primary registry, such as the Iranian Registry of Clinical Trials or other WHO-recognized registries.
Fundamental Errors in Published Works
When an author discovers a significant error or inaccuracy in their published work, it is the author’s obligation to notify the journal editor promptly and cooperate with the editor to retract or correct the paper.
Duties of Reviewers
Contribution to Editorial Decisions
Peer review assists the Editor-in-Chief and the editorial board in making editorial decisions, and through editorial communications with the author, it may assist the author in improving the quality of the paper.
Confidentiality
Any manuscripts received for review are confidential documents and must be treated as such. They must not be shown to or discussed with others without authorization from the Editor-in-Chief. Unpublished materials disclosed in a submitted manuscript must not be used in a reviewer’s own research without the express written consent of the author.
Objectivity and Standards of Review
Reviews should be conducted objectively. Personal criticism of the author is inappropriate. Referees should express their views clearly with supporting scientific arguments. Reviewers should identify relevant published work that has not been cited by the authors, and note any substantial similarity between the manuscript under consideration and other published works.
Promptness and Competing Interests
Any selected referee who feels unqualified to review the research reported in a manuscript, or knows that its prompt review will be impossible, should notify the editor promptly and decline the review invitation. Reviewers must not evaluate manuscripts in which they have conflicts of interest resulting from competitive, collaborative, or other relationships with any of the authors, companies, or institutions connected to the papers.
Duties of Editors
Editorial Independence and Fair Play
The Editor-in-Chief has complete authority over the editorial content of the journal and the timing of publication. Manuscripts are evaluated exclusively on their academic merit, scientific rigor, clarity, and relevance to the scope of the journal, without regard to the authors’ race, gender, sexual orientation, religious belief, ethnic origin, citizenship, or political philosophy. Editorial decisions are independent of commercial or institutional interests associated with Shahid Beheshti University of Medical Sciences.
Confidentiality
The Editor-in-Chief, the Journal Manager, and the editorial staff must not disclose any information about a submitted manuscript to anyone other than the corresponding author, reviewers, potential reviewers, and the publisher, as appropriate.
Review Process Oversight
The editorial board ensures that all submitted manuscripts being considered for publication undergo double-blind peer review by at least three independent external reviewers with specialized expertise. The identities of authors and reviewers remain concealed during the process.
Conflicts of Interest in Editorial Submissions
Editors and editorial board members must recuse themselves from editorial decisions on manuscripts that they have authored or that have been written by family members, colleagues, or institutional associates. In such cases, an independent handling editor oversees the peer-review process, and the manuscript is subjected to the same procedures as any standard submission.
Investigation of Misconduct
The Editor-in-Chief, guided by COPE flowcharts, investigates suspected research or publication misconduct, including plagiarism, data fabrication, improper authorship, and citation manipulation, even if discovered years after publication. Such investigations may involve seeking clarification from the authors, consulting independent experts, and contacting authors’ host institutions or regulatory bodies.
Integrity of the Scholarly Record
When genuine errors or scientific miscon duct are confirmed, the Editor-in-Chief coordinates the publication of prompt corrections, editorial expressions of concern, or retractions. Retractions adhere strictly to COPE Retraction Guidelines, clearly explaining the reasons for retraction and remaining permanently linked to the online version of the article.
Duties of the Publisher
Support for Editorial Integrity
The Pharmaceutical Sciences Research Center at Shahid Beheshti University of Medical Sciences ensures that editorial independence is respected and preserved. The publisher does not interfere with editorial decisions or seek to influence manuscript acceptance.
Publication Ethics Oversight
The publisher works with the editorial board to uphold high ethical standards, monitoring journal practices to align with international publishing benchmarks. In cases of alleged research misconduct, the publisher assists the editorial office in conducting fair and objective inquiries.
Access, Archiving, and Financial Transparency
The publisher supports the continuous digital availability and long-term archiving of published papers. The journal does not charge submission fees, editorial processing fees, or article processing charges. The financial support provided by the host institution does not affect editorial determinations or the assessment of submitted manuscripts.